National Institutes of Health

National Institutes of Health

National Institutes of Health (NIH) is a government agency of the United States whose mission is to seek knowledge about the nature and behavior of living systems and to apply that knowledge to enhance health, lengthen life and reduce illness and disability. The NIH provides leadership, conducts and supports research and information dissemination.

The National Institutes of Health (NIH) is a government agency of the United States whose mission is to seek knowledge about the nature and behavior of living systems and to apply that knowledge to enhance health, lengthen life and reduce illness and disability. NIH works to develop, maintain and renew scientific human and physical resource to ensure the capability of the U.S. to prevent disease. The NIH aims to enhance the economic well-being of the U.S. by expanding the knowledge base in medical and associated sciences and ensuring high return on public investment in research. One of the goals of the NIH is to promote the highest level of scientific integrity, public accountability and social responsibility in the conduct of science.

The NIH provides leadership by conducting and supporting research in the following areas: Diagnosis, prevention and cures for human diseases; Human growth and development; Biological effect of environmental contaminants; Mental, addictive and physical disorders; Programs for collection, dissemination and exchange of information in medicine and health, including training of medical librarians and health information specialists.

Timeline

2015
President Obama’s Precision Medicine Initiative (PMI) launched
2013
An agreement was reached between the National Institutes of Health and the Henrietta Lacks family regarding the use of the HeLa genome for research.
1997
A team led by NIH-funded scientists determined the complete genome sequence of the E. coli bacterium
1990
Beginning of the U.S. Human Genome Project, sponsored by the Department of Energy (DOE) and the NIH and part of the international Human Genome Project (HGP) which ran until 2003
1988
Recognizing the importance of computerized information processing methods for the conduct of biomedical research, Congress establishes the National Center for Biotechnology Information (NCBI) as a division of the National Library of Medicine
May 1930
The Ransdell Act redesignated the Hygienic Laboratory as the National Institute of Health, authorizing $750,000 for construction of two buildings for NIH, and creating a system of fellowships.
1887
A bacteriological laboratory, known as the Laboratory of Hygiene, was established under Dr. Joseph J. Kinyoun at the Marine Hospital, Staten Island, N.Y., in August, for research on cholera and other infectious diseases (renamed Hygienic Laboratory in 1891.)

Funded Companies

Company
Description
Industry
Website
Location
Recursion Pharmaceuticals

A biotechnology and data science company based in Salt Lake City, Utah, founded in 2013, that combines biology with artificial intelligence for drug discovery. Using human cell models of diseases, Recursion captures microscopic images to build biological datasets and computational techniques identify disease-associated biological changes.

Innovative Biochips (iBioChips) is a Sugar Land, Texas-based biotechnology company developing biosensors and lab-on-chip bioassays.

A biotechnology company known for developing small-molecule pharmaceuticals for infectious diseases, inflammatory diseases and cancer. It was founded in 1986 and has headquarters in Durham, North Carolina.

Envisagenics is a biotechnology company founded by Maria Luisa Pineda and Martin Akerman in 2014 and headquartered in New York City, New York using artificial intelligence and RNA sequencing to develop therapeutics to treat genetic diseases.

A medical company in Massachusetts focusing on lowering the cost of vaccine distribution.

A life science instrumentation company developing ellipsometry analysis systems for microplates and slide disposables

A computational immunology and vaccine development company based in Providence, Rhode Island. It was founded in 1998.

Helix is a San Mateo, California-based personal genomics company founded in 2015 by Scott Burke, James Lu and Justin Kao.

SAB Biotherapeutics is a therapeutics and immunotherapy research and development company based in Sioux Falls, South Dakota.

Aldatu Biosciences is a Cambridge, Massachusetts-based medical diagnostics company offering diagnostic tools and a proprietary genotyping platform.

Crinetics Pharmaceuticals is a San Diego-based company founded in 2008 by Scott Struthers, Stephen F. Betz and Yun-Fei Zhu.

Cayman Chemical Company is an Ann Arbor, Michigan-based biotechnology company manufacturing healthcare and research diagnostic tools including assay kits, antibodies, proteins, and biochemicals.

New york technology company specializing in the research and development of open-source software in the fields of computer vision, medical imaging, visualization, 3d data publishing and technical software development

Aqualung Therapeutics is a Tucson, Arizona-based biotechnology company developing anti-inflammatory monoclonal antibody products.

A bio-therapeurtics company developing therapies for inflammatory diseases

Microvascular Therapeutics is a Tuscon, Arizona-based biotechnology company.

Etubics is a Seattle-based company founded in 2003 by Frank R. Jones.

Integrated BioTherapeutics is a Rockville, Maryland-based company founded in 2005 by M. Javad Aman.

Novilytic is a West Lafayette, Indiana-based biochemistry analytics company developing diagnostic tools and technology for protecting and securing drugs and medical devices founded in 2013 by Fred Regnier.

Talis Biomedical is a Menlo Park, California-based medical diagnostics company providing diagnostic testing for infectious disease founded in 2010 by BRIAN COE, M.B.A..

22 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Alfred C. Johnson, Ph.D.

Deputy Director for Management

Carrie D. Wolinetz, Ph.D.

Acting Chief of Staff

Francis S. Collins

Director

James M. Anderson, M.D., Ph.D.

Deputy Director for Program Coordination, Planning, and Strategic Initiatives

Lawrence A. Tabak, D.D.S., Ph.D.

Deputy Director

Michael M. Gottesman, M.D.

Deputy Director

Michael S. Lauer, M.D.

Deputy Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Eli Lilly and Company
February 26, 2021
www.prnewswire.com:443
/PRNewswire/ -- The U.S. government has agreed to purchase a minimum of 100,000 doses of bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg...
SHEPHERD Therapeutics
February 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, today announced a collaboration with...
Avexegen Therapeutics Inc.
February 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- Avexegen Therapeutics Inc. today announced that it has received a Phase 2 award of $2.94 million under the National Institutes of Health's...
Emmes
February 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical...
Connectyx Technologies Holdings Group, Inc.
February 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) ("Connectyx" or the "Company"), a development-stage biomedical company focusing on...
Versiti, Inc.
January 28, 2021
www.prnewswire.com:443
/PRNewswire/ -- The Versiti Blood Research Institute has been awarded a $12.3 million research grant by the National Institutes of Health's (NIH) National...
Ride Health
January 20, 2021
www.prnewswire.com:443
/PRNewswire/ -- Ride Health, coordinating smarter transportation for every patient need, is partnering with the COVID-19 Prevention Trials Network (CoVPN), a...
January 19, 2021
WebWire
Discovery, the global leader in real-life entertainment, and UNICEF USA, supporting the largest single vaccine buyer in the world, today announced an innovative new partnership to assist UNICEF USA in providing 2 billion doses of COVID-19 vaccines for frontline health care workers and vulnerable populations in 92 low-and middle-income countries. As part of its RISE (Reducing Inequality and Supporting Empowerment) Initiative, Discovery will donate $1 for every new discovery+ subscription...
Syntegra
January 18, 2021
www.prnewswire.com:443
/PRNewswire/ -- Today Syntegra and the National Institutes of Health (NIH) have announced a collaboration to validate Syntegra's AI-enabled synthetic data...
CND Life Sciences
January 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- CND Life Sciences (cndlifesciences.com), an innovative medical technology company pioneering the detection, visualization, and quantification...
Sara Harrison
December 29, 2020
Wired
With lots of research, arrows, and an inviting color palette, artists helped transform complex research into useful information.
National Eczema Association
December 22, 2020
www.prnewswire.com:443
/PRNewswire/ -- The National Eczema Association (NEA) today announced the recipients for its 2020 research grants. Out of a record number of U.S.-based and...
Melissa Healy
December 21, 2020
Los Angeles Times
British scientists have found a version of the coronavirus with a cluster of genetic changes that make it more transmissible and perhaps more dangerous.
Melissa Healy
December 19, 2020
Los Angeles Times
Americans waiting their turn for a COVID-19 vaccine may not be pleased to see who's in line ahead of them. Does a prisoner or smoker deserve it more?
BioSpace
November 17, 2020
BioSpace
Initial Appointments Include Internationally Recognized Experts: Fred D. Lublin, M.D.; Bruce E. Sands, M.D., M.S.; Jerrold R. Turner, M.D., Ph.D. and Paul J. Utz, M.D.
Immunic, Inc.
November 17, 2020
www.prnewswire.com:443
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at...
BioSpace
November 10, 2020
BioSpace
Medigen Vaccine Biologics Corporation (MVC) (TPEx: 6547.TWO), a biopharmaceutical company focusing on the development and production of vaccines and biologics, and BlueWillow Biologics, Inc., a privately held clinical-stage biopharmaceutical company developing intranasal vaccines through its patented NanoVaxTM adjuvant, today announced a partnership to develop S-2P-NE-01
BioSpace
November 9, 2020
BioSpace
Armis Biopharma, Inc. announced that the National Institutes of Health (NIH) recently awarded the company a grant in the amount of $423,048 to support development of a novel product for skin decontamination after exposure to chemical warfare agents. This is the first phase of a $2.1 million grant. The project support
November 6, 2020
WebWire
An enzyme that helps COVID-19 (coronavirus) infect the body also plays a role in inflammation and patient outcomes in inflammatory bowel disease (IBD), according to a new study led by Cedars-Sinai. The findings raise the possibility that anti-inflammatory drug therapies for IBD may aid recovery from coronavirus. The multisite study, led by Cedars-Sinai and published today in the journal Gastroenterology, focused on angiotensin-converting enzyme 2 (ACE2), which normally plays a cruci...
November 3, 2020
WebWire
Blood clots continue to wreak havoc for patients with severe COVID-19 infection, and a new study explains what may spark them in up to half of patients. The culprit: an autoimmune antibody that's circulating in the blood, attacking the cells and triggering clots in arteries, veins, and microscopic vessels. Blood clots can cause life-threatening events like strokes. And, in COVID-19, microscopic clots may restrict blood flow in the lungs, impairing oxygen exchange. Outside of novel corona...
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.